Wei Lin
Chief Tech/Sci/R&D Officer at REVOLUTION MEDICINES, INC.
Net worth: 3 M $ as of 30/03/2024
Wei Lin active positions
| Companies | Position | Start | End |
|---|---|---|---|
| 2SEVENTY BIO, INC. | Director/Board Member | 06/03/2023 | - |
| Independent Dir/Board Member | 06/03/2023 | - | |
| REVOLUTION MEDICINES, INC. | Chief Tech/Sci/R&D Officer | 31/03/2023 | - |
Career history of Wei Lin
Former positions of Wei Lin
| Companies | Position | Start | End |
|---|---|---|---|
| ERASCA, INC. | Chief Tech/Sci/R&D Officer | 31/12/2020 | 09/04/2023 |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 13/11/2018 | 04/01/2021 |
| Roche (China) Co. Ltd. | Corporate Officer/Principal | 31/12/2005 | 31/12/2008 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Training of Wei Lin
| Haverford College | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Statistics
International
| United States | 8 |
| China | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| REVOLUTION MEDICINES, INC. | Health Technology |
| ERASCA, INC. | Health Technology |
| 2SEVENTY BIO, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Roche (China) Co. Ltd. |
- Stock Market
- Insiders
- Wei Lin
- Experience
